Skip to content
10-Q

Quarterly Report

DARA BioSciences, Inc.

0001214659-14-007437

← back to feed
Filed
Nov 5, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 4, 2014 19.59M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 $16.68M
Stockholders Equity Q3 2014 · Dec 31, 2013 $6.61M
Current Liabilities Q3 2014 · Sep 30, 2014 $2.26M
Current Liabilities Q3 2014 · Dec 31, 2013 $1.68M
Total Liabilities Q3 2014 · Sep 30, 2014 $3.07M
Total Liabilities Q3 2014 · Dec 31, 2013 $2.43M
Current Assets Q3 2014 · Sep 30, 2014 $14.89M
Current Assets Q3 2014 · Dec 31, 2013 $3.89M
Total Assets Q3 2014 · Sep 30, 2014 $18.53M
Total Assets Q3 2014 · Dec 31, 2013 $7.99M
Capex Q3 2014 · Sep 30, 2013 $12.22K
Operating Cash Flow Q3 2014 · Sep 30, 2013 −$7.53M
Cash And Equivalents Q3 2014 · Sep 30, 2013 $2.58M
Cash And Equivalents Q3 2014 · Jan 1, 2013 $6.5M
Sga Expense Q3 2014 · Sep 30, 2013 $937.62K
Sga Expense Q3 2014 · Sep 30, 2013 $3.38M
Rd Expense Q3 2014 · Sep 30, 2013 $453.02K
Rd Expense Q3 2014 · Sep 30, 2013 $1.65M
Net Income Q3 2014 · Sep 30, 2013 −$2.53M
Net Income Q3 2014 · Sep 30, 2013 −$7.61M
Operating Income Q3 2014 · Sep 30, 2013 −$2.62M
Operating Income Q3 2014 · Sep 30, 2013 −$8.08M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $124.05K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $150.31K
Revenue Q3 2014 · Sep 30, 2013 $138.89K
Revenue Q3 2014 · Sep 30, 2013 $237K